Generate Biomedicines, Inc. Announces Pricing of Initial Public Offering
Generate Biomedicines official news-release RSS · Indexed industry source record · Source published: Thu Feb 26 2026 23:11:00 GMT+0000 (Coordinated Universal Time) · Indexed here: Thu Oct 08 2026 09:07:27 GMT+0000 (Coordinated Universal Time)
Saved source excerpt
SOMERVILLE, Mass., February 26, 2026 — Generate Biomedicines, Inc. (Nasdaq: GENB) (“Generate”), a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development, today announced the pricing of its initial public offering of 25,000,000 shares of common stock at a public offering price of $16.00 per share. The gross proceeds from the offering
This is a cited excerpt from the source. Read the original link for the complete text. Automated indexing and topic classification do not constitute fact verification.